SPONSOR
Radboud University Medical Center
Total Trials
13
Recruiting
13
Phases
Phase 3, Phase 2, Phase 3, Phase 4
Conditions studied: Cognitive ChangePostoperative DeliriumPostoperative Cognitive DysfunctionThoracic Aortic AneurysmCochlear ImplantsHearing Loss, SensorineuralParkinson's Disease (PD)Freezing of GaitFreezing of Gait Symptoms in Parkinson DiseaseParkinson Disease
Radboud University Medical Center is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Cognitive Change, Postoperative Delirium, Postoperative Cognitive Dysfunction, Thoracic Aortic Aneurysm.
The trial portfolio spans Phase 3, Phase 2, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Radboud University Medical Center
How many clinical trials has Radboud University Medical Center sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Radboud University Medical Center, of which 13 are actively recruiting participants. These trials cover conditions including Cognitive Change, Postoperative Delirium, Postoperative Cognitive Dysfunction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Radboud University Medical Center research focus on?
Radboud University Medical Center clinical trials span Cognitive Change, Postoperative Delirium, Postoperative Cognitive Dysfunction, Thoracic Aortic Aneurysm, Cochlear Implants, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Radboud University Medical Center clinical trial?
To participate in a Radboud University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Radboud University Medical Center trials with current recruitment status updated daily.
Clinical Trials by Radboud University Medical Center
NCT06330090
Recruiting
COgnitive Dynamics in Early Childhood
Cognitive Change
NCT04523909
Recruiting
Trajectory of Neuroinflammatory Markers in Cerebrospinal Fluid Prior to and After Thoracic Aortic Surgery
Postoperative Delirium
NCT06453343
Recruiting
Clinical Trial to Compare Two Surgical Approaches to the Cochlea
Cochlear Implants
NCT07316296 Phase 3
Recruiting
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Parkinson's Disease (PD)
NCT06074614
Recruiting
Neural Control of Breathing in Parkinson's Disease
Parkinson Disease
NCT06911190
Recruiting
Ten Year Follow-up in FSHD: the FOCUS 3 Study
FSHD - Facioscapulohumeral Muscular Dystrophy
NCT06512493
Recruiting
South East (Zuid Oost) Netherlands Heart Registry
Coronary Artery Disease
NCT07163611 Phase 2, Phase 3
Recruiting
Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
Membranous Nephropathy - PLA2R Induced
NCT05192057 Phase 4
Recruiting
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
Nontuberculous Mycobacterial Lung Disease
NCT05267379
Recruiting
An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
Post-ERCP Acute Pancreatitis
NCT03621904
Recruiting
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Endometrial Cancer Stage III
NCT07929831
Recruiting
The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional Capacity
Obesity & Overweight
NCT06082492
Recruiting
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
Stage III Non-small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology